Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Bulletin Du Cancer|January 1, 1997
[Vaccination against the tumoral mammary epithelial cells expressing MUC1 mucin]S M Scholl, P PouillartEndocrinology|August 1, 1983
Antiestrogenic effects of LY 117018 in MCF-7 cellsS M Scholl, K K Huff, M E LippmanInternational Journal of Cancer|February 15, 1985
Prevalence of human papillomavirus type 16 DNA in cervical carcinoma samples in East AngliaS M Scholl, E M Pillers, R E Robinson, et al.Bulletin Du Cancer|January 1, 1993
[CSF-1 (colony stimulating factors 1) and CSF-1 receptor. General review and expression in invasive breast tumors]F Beuvon, C Palud, R Tang, et al.International Journal of Radiation Oncology, Biology, Physics|October 1, 1996
Metachronous contralateral breast cancer as first event of relapseA de la Rochefordière, E Mouret-Fourme, B Asselain, et al.Journal of the National Cancer Institute|January 19, 1994
Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosisS M Scholl, C Pallud, F Beuvon, et al.Breast Cancer Research and Treatment|June 16, 1999
Analyzing prognostic factors in breast cancer using a multistate modelP Broët, A de la Rochefordière, S M Scholl, et al.Bulletin Du Cancer|October 1, 1996
[Contralateral breast cancer: metastasis or second primary cancer?]P Broët, A de la Rochefordière, S M Scholl, et al.Breast Cancer Research and Treatment|February 16, 2000
Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trialP Broët, S M Scholl, A de la Rochefordière, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Contralateral breast cancer: annual incidence and risk parametersP Broët, A de la Rochefordière, S M Scholl, et al.Pageof 3